mWIG40/ PL9999999912
PL9999999912| 2024-07-02 5:09:45 PM | Chg. -100.0 | Open | High | Low | Previous Close |
|---|---|---|---|---|---|
| 6,400.8PLN | -1.54% | 6,501.3 | 6,504.3 | 6,391.8 | 6,500.8 |
GlobeNewswire
2023-12-11
Ryvu Therapeutics Presents Data on RVU120 at the 2023 American Society of Hematology (ASH) Annual Me...
GlobeNewswire
2023-12-07
Ryvu Therapeutics Presents Data on RVU120 at the San Antonio Breast Cancer Symposium 2023
GlobeNewswire
2023-11-29
Ryvu Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
GlobeNewswire
2023-10-23
Ryvu Therapeutics Provides an Update on the Progress of RVU120 Phase I Studies in Patients with Soli...
GlobeNewswire
2023-10-04
Ryvu Therapeutics to Present Preclinical Data on PRMT5 and its Synthetic Lethality Platform at the 2...
GlobeNewswire
2023-09-13
Ryvu Therapeutics Reports 2023 Half-Year Financial Results and Provides Corporate Update
